Concepedia

Isabel Figueroa

IF

Statistics

Publications

11

Citations

729

H-Index

11

Active since

2012

Affiliations

WuXi AppTec (China)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Genesys (United States)

AbbVie (United States)

Ambrx (United States)

Isabel Figueroa is an author at WuXi AppTec (China) specializing in pharmacy, antibody-drug conjugates, and pharmacology.

Publications per year

2012–2020

11

Publications

11

Antibody Conjugation of a Chimeric BET Degrader Enables <i>in vivo</i> Activity

Thomas H. Pillow, Pragya Adhikari, Robert A. Blake et al. · ChemMedChem · 2019 · 196 citations

Pharmacy, Medicinal Chemistry, Oncology +17

Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin

Isabel Figueroa, Stuart Johnson, Susan P. Sambol et al. · Clinical Infectious Diseases · 2012 · 147 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +13

Discovery of Pyrophosphate Diesters as Tunable, Soluble, and Bioorthogonal Linkers for Site-Specific Antibody–Drug Conjugates

Jeffrey C. Kern, Mark T. Cancilla, Deborah Dooney et al. · Journal of the American Chemical Society · 2016 · 141 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune Cells

Philip E. Brandish, Anthony Palmieri, S. V. Antonenko et al. · Bioconjugate Chemistry · 2018 · 58 citations

Pharmacy, Immunology, Pharmacology +17

Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy

Irene Tom, Victoria C. Pham, Kenneth J. Katschke et al. · Proceedings of the National Academy of Sciences · 2020 · 57 citations · Full text

Medicine, Molecular Biology, Ophthalmology +15

1–5 of 11